Marker Therapeutics, Inc. (11)
Browse by Contract Category
Contracts
-
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Marker Therapeutics, Inc. 2020 Equity Incentive Plan
(Filed With SEC on November 9, 2020)
-
Description of Common Stock of Marker Therapeutics, Inc
(Filed With SEC on March 12, 2020)
-
Exclusive License Agreement between Baylor College of Medicine and Marker Therapeutics, Inc. dated March 16, 2018
(Filed With SEC on March 15, 2019)
-
Sponsored Research Contract between Baylor College of Medicine and Marker Therapeutics, Inc. dated November 16, 2018
(Filed With SEC on March 15, 2019)
-
Form of Director and Officer Indemnification Agreement
(Filed With SEC on March 15, 2019)
-
Form of Stock Option Grant Notice and Stock Option Agreement under the Marker Therapeutics, Inc. 2020 Equity Incentive Plan
(Filed With SEC on November 9, 2020)
-
Registration Rights Agreement, dated February 28, 2020, between Marker Therapeutics, Inc. and Aspire Capital Fund, LLC
(Filed With SEC on March 2, 2020)
-
Common Stock Purchase Agreement, dated February 28, 2020, between Marker Therapeutics, Inc. and Aspire Capital Fund, LLC
(Filed With SEC on March 2, 2020)
-
Employment Agreement by and between Mythili Koneru and the Company dated February 6, 2019
(Filed With SEC on May 10, 2019)
-
Consulting Agreement between Dr. Ann Leen and Marker Therapeutics, Inc. dated October 19, 2018
(Filed With SEC on March 15, 2019)
-
Amendment to Employment Agreement between Marker Therapeutics, Inc. and Peter Hoang, dated March 14, 2019
(Filed With SEC on March 15, 2019)